Omeros (OMER) News Today $8.92 +0.40 (+4.69%) Closing price 04:00 PM EasternExtended Trading$8.73 -0.19 (-2.13%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025March 26 at 9:40 AM | investing.comOmeros to activate site for Phase III programme of zaltenibart for PNHMarch 24 at 8:41 AM | finance.yahoo.comOmeros provides update on zaltenibart trialMarch 22, 2025 | markets.businessinsider.comD. Boral Capital Reaffirms Buy Rating for Omeros (NASDAQ:OMER)D. Boral Capital reaffirmed a "buy" rating and issued a $36.00 target price on shares of Omeros in a research note on Friday.March 22, 2025 | marketbeat.comCorient Private Wealth LLC Has $7.25 Million Holdings in Omeros Co. (NASDAQ:OMER)Corient Private Wealth LLC trimmed its holdings in Omeros Co. (NASDAQ:OMER - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 733,449 shares of the biopharmaceutical company's stockMarch 22, 2025 | marketbeat.comOmeros (OMER) Expected to Announce Quarterly Earnings on MondayMarch 22, 2025 | americanbankingnews.comOmeros (OMER) Expected to Announce Earnings on MondayOmeros (NASDAQ:OMER) will be releasing earnings after the market closes on Monday, March 24, Financial Modeling Prep reports.March 22, 2025 | marketbeat.comOmeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial ProgramMarch 21, 2025 | businesswire.com113,326 Shares in Omeros Co. (NASDAQ:OMER) Acquired by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Omeros Co. (NASDAQ:OMER - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 113,326 shares of the biopharmaceutical coMarch 21, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Downgraded to "Sell" Rating by StockNews.comMarch 21, 2025 | americanbankingnews.comOmeros (NASDAQ:OMER) Downgraded by StockNews.com to SellStockNews.com cut Omeros from a "hold" rating to a "sell" rating in a research report on Friday.March 21, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Stock Rating Upgraded by StockNews.comStockNews.com raised shares of Omeros from a "sell" rating to a "hold" rating in a research note on Thursday.March 13, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from AnalystsOmeros Co. (NASDAQ:OMER - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy ratinMarch 8, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Lowered to Sell Rating by StockNews.comStockNews.com downgraded Omeros from a "hold" rating to a "sell" rating in a research note on Wednesday.March 6, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?Omeros (NASDAQ:OMER) Stock Passes Above 200-Day Moving Average - Here's WhyMarch 1, 2025 | marketbeat.comOmeros Corporation: Scientifically Compelling Again, But The Delay Has Cost UsFebruary 24, 2025 | seekingalpha.comINGALLS & SNYDER LLC Reduces Stake in Omeros Corp: A Strategic Portfolio AdjustmentFebruary 23, 2025 | gurufocus.comOmeros announces results for narsoplimab expanded access programFebruary 21, 2025 | finance.yahoo.comOmeros (NASDAQ:OMER) Given Buy Rating at D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and issued a $36.00 price objective on shares of Omeros in a research report on Thursday.February 21, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 6.9% - Here's What HappenedOmeros (NASDAQ:OMER) Trading 6.9% Higher - Time to Buy?February 21, 2025 | marketbeat.comOmeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMAFebruary 20, 2025 | uk.finance.yahoo.comOmeros (NASDAQ:OMER) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?Omeros (NASDAQ:OMER) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?February 19, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Given Average Rating of "Moderate Buy" by AnalystsShares of Omeros Co. (NASDAQ:OMER - Get Free Report) have earned an average rating of "Moderate Buy" from the five analysts that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy ratFebruary 11, 2025 | marketbeat.comInstitutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the companyFebruary 10, 2025 | finance.yahoo.comOmeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access ProgramFebruary 10, 2025 | businesswire.com40,000 Shares in Omeros Co. (NASDAQ:OMER) Purchased by Stordahl Capital Management Inc.Stordahl Capital Management Inc. acquired a new stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 40,000 shares of the biopharmaJanuary 30, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 5.3% - Here's What HappenedOmeros (NASDAQ:OMER) Trading Up 5.3% - What's Next?January 27, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Shares Down 4.4% - What's Next?Omeros (NASDAQ:OMER) Stock Price Down 4.4% - What's Next?January 24, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Shares Gap Down - Time to Sell?Omeros (NASDAQ:OMER) Shares Gap Down - Here's What HappenedJanuary 22, 2025 | marketbeat.comBrokers Offer Predictions for Omeros FY2025 EarningsOmeros Co. (NASDAQ:OMER - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Omeros in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst O. Brayer anticipates that the biopharmaceutical company will post earnings of ($1.73) peJanuary 22, 2025 | marketbeat.comBarclays PLC Has $376,000 Holdings in Omeros Co. (NASDAQ:OMER)Barclays PLC grew its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 121.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 94,640 shares of the biopharmaceutical company's stock after purchasing an additional 51,873 shares durJanuary 19, 2025 | marketbeat.comOmeros' (OMER) "Hold" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Omeros in a research report on Friday.January 17, 2025 | marketbeat.comNarsoplimab shows promise in reducing mortality for TA-TMA patientsJanuary 16, 2025 | msn.comOmeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary EndpointJanuary 16, 2025 | finance.yahoo.comOmeros (NASDAQ:OMER) Shares Up 5.5% - Here's What HappenedOmeros (NASDAQ:OMER) Stock Price Up 5.5% - Time to Buy?January 16, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and issued a $36.00 price target on shares of Omeros in a report on Thursday.January 16, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Shares Down 3.1% - Here's WhyOmeros (NASDAQ:OMER) Stock Price Down 3.1% - Should You Sell?January 6, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Shares Acquired by Barclays PLCBarclays PLC increased its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 121.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 94,640 shares of the biopharmaceutical company's stock after puJanuary 4, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 10.3% - Here's What HappenedOmeros (NASDAQ:OMER) Stock Price Up 10.3% - What's Next?January 3, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Shares Gap Up - Should You Buy?Omeros (NASDAQ:OMER) Shares Gap Up - Should You Buy?December 31, 2024 | marketbeat.comOmeros (NASDAQ:OMER) Shares Gap Down - What's Next?Omeros (NASDAQ:OMER) Shares Gap Down - Here's WhyDecember 30, 2024 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 3.6% - Should You Buy?Omeros (NASDAQ:OMER) Shares Up 3.6% - Still a Buy?December 27, 2024 | marketbeat.comWhen Can We Expect A Profit From Omeros Corporation (NASDAQ:OMER)?December 27, 2024 | finance.yahoo.comOmeros initiated with a Buy at D. Boral CapitalDecember 24, 2024 | markets.businessinsider.comOmeros (NASDAQ:OMER) Shares Gap Down - Should You Sell?Omeros (NASDAQ:OMER) Shares Gap Down - Here's What HappenedDecember 24, 2024 | marketbeat.comD. Boral Capital Initiates Coverage of Omeros (OMER) with Buy RecommendationDecember 24, 2024 | msn.comThis Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayDecember 23, 2024 | benzinga.comOmeros (NASDAQ:OMER) Now Covered by D. Boral CapitalD. Boral Capital initiated coverage on shares of Omeros in a research note on Monday. They issued a "buy" rating and a $36.00 price objective for the company.December 23, 2024 | marketbeat.comOmeros reports survival benefit with narsoplimab in TA-TMADecember 21, 2024 | uk.investing.comWellington Management Group LLP Invests $305,000 in Omeros Co. (NASDAQ:OMER)Wellington Management Group LLP purchased a new position in shares of Omeros Co. (NASDAQ:OMER - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 76,945 shares of the biopharmaceutical company's stock, vaDecember 21, 2024 | marketbeat.com Remove Ads Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address OMER Media Mentions By Week OMER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMER News Sentiment▼0.460.78▲Average Medical News Sentiment OMER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMER Articles This Week▼132▲OMER Articles Average Week Remove Ads Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SUPN News PCRX News NKTR News ASMB News CPIX News LLY News JNJ News ABBV News MRK News PFE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMER) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omeros Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omeros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
